You are here

Newborn Screening Increases Survival Outcome for Patients With SCID

WASHINGTON, Jan. 27, 2011 /PRNewswire-USNewswire/ -- Severe Combined Immunodeficiency (SCID) occurs in just one out of every 50,000 to 100,000 births in the United States, yet it is the most serious primary immunodeficiency disorder.(1) A study published today in Blood, the Journal of the American Society of Hematology (ASH), demonstrates that babies with SCID who are diagnosed at birth and receive a hematopoietic stem cell transplant (HSCT), which is the transplantation of blood-forming stem cells, have significantly improved survival.

Newborn Screening Increases Survival Outcome for Patients With Severe Combined Immunodeficiency

News Category: